These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7640064)

  • 21. [Hematopoietic growth factors in the treatment of acute myeloblastic leukemia].
    de la Rubia Comos J
    Sangre (Barc); 1997 Apr; 42 Suppl 1():32-3. PubMed ID: 9381298
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical use of hematopoietic growth factors.
    Löwenberg B; Dale DC; Sheridan WP
    Rev Invest Clin; 1994 Apr; Suppl():33-40. PubMed ID: 7886306
    [No Abstract]   [Full Text] [Related]  

  • 23. Haemopoietic growth factors.
    Devereux S; Linch D
    Q J Med; 1990 Jun; 75(278):537-50. PubMed ID: 2217663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hematopoietic growth factors in hematological malignancies.
    Kumar R; Rao RR; Ranjan S
    J Assoc Physicians India; 1995; Suppl 3():5-10. PubMed ID: 8773114
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfusion support of hematology and oncology patients. The role of recombinant hematopoietic growth factors.
    Cottler-Fox M; Klein HG
    Arch Pathol Lab Med; 1994 Apr; 118(4):417-20. PubMed ID: 7909429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hematopoietic growth factors. Current status of therapy].
    Hiddemann W
    Internist (Berl); 1994 Apr; 35(4):395-400. PubMed ID: 7515381
    [No Abstract]   [Full Text] [Related]  

  • 27. Growth factors of the future.
    Nemunaitis J
    Leuk Lymphoma; 1993 Mar; 9(4-5):329-36. PubMed ID: 8348068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The importance of dose: lymphomas as a model of chemosensitive malignancies.
    Bronchud MH
    Eur J Cancer; 1993; 29A Suppl 5():S17-22. PubMed ID: 8260261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of in vivo administration of recombinant methionyl human stem cell factor on the number of human marrow hematopoietic stem cells.
    Tong J; Gordon MS; Srour EF; Cooper RJ; Orazi A; McNiece I; Hoffman R
    Trans Assoc Am Physicians; 1993; 106():134-44. PubMed ID: 7518622
    [No Abstract]   [Full Text] [Related]  

  • 30. [Importance of recombinant proteins in the adjuvant treatment of cancer].
    Cheron JM
    Ann Pharm Fr; 1998; 56(6):241-3. PubMed ID: 9872009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro biological activities of the haemopoietic growth factors: implications for their clinical use.
    Testa NG
    Acta Haematol; 1991; 86(3):122-7. PubMed ID: 1785226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemopoietic growth factors.
    Ketley NJ; Newland AC
    Postgrad Med J; 1997 Apr; 73(858):215-21. PubMed ID: 9156123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematopoietic growth factors in myelodysplastic syndromes.
    Blinder VS; Roboz GJ
    Curr Hematol Rep; 2003 Nov; 2(6):453-8. PubMed ID: 14561388
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Haemopoietic growth factors.
    Khwaja A; Goldstone AH
    BMJ; 1991 May; 302(6786):1164-5. PubMed ID: 2043807
    [No Abstract]   [Full Text] [Related]  

  • 35. Evaluation of haematopoietic growth factors: defining relevant clinical endpoints in growth factor trials.
    Linch DC
    Eur J Cancer; 1994; 30A Suppl 3():S40-3. PubMed ID: 7695958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Haemopoietic growth factor and dose intensity in high-grade and intermediate-grade lymphoma.
    Pettengell R; Crowther D
    Ann Oncol; 1994; 5 Suppl 2():133-41. PubMed ID: 7911317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hematopoietins: biology, pathophysiology, and potential as therapeutic agents.
    Mertelsmann R
    Ann Oncol; 1991 Apr; 2(4):251-63. PubMed ID: 1868020
    [No Abstract]   [Full Text] [Related]  

  • 38. High dose chemotherapy with haemopoietic support for breast cancer.
    Steward WP
    Eur J Cancer; 1995; 31A Suppl 7():S21-4. PubMed ID: 8562187
    [No Abstract]   [Full Text] [Related]  

  • 39. The use of haemopoietic growth factors in blood disorders.
    Hann IM
    Arch Dis Child; 1994 Dec; 71(6):543-7. PubMed ID: 7726619
    [No Abstract]   [Full Text] [Related]  

  • 40. Do haemopoietic growth factors increase the efficacy of aggressive therapy of ANLL in elderly patients?
    Mandelli F; Petti MC
    Hematol Oncol; 1993; 11 Suppl 1():9-11. PubMed ID: 7683626
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.